GPCR
Price:
$36.95
Market Cap:
$2.11B
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pu...[Read more]
Industry
Biotechnology
IPO Date
2023-02-03
Stock Exchange
NASDAQ
Ticker
GPCR
According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -20.15%. This represents a change of 201.90% compared to the average of -6.67% of the last 4 quarters.
The mean historical ROE of Structure Therapeutics Inc. over the last ten years is 38.56%. The current -20.15% ROE has changed -152.25% with respect to the historical average. Over the past ten years (40 quarters), GPCR's ROE was at its highest in in the December 2021 quarter at 23.84%. The ROE was at its lowest in in the March 2022 quarter at -12.80%.
Average
38.56%
Median
51.67%
Minimum
-19.77%
Maximum
70.66%
Discovering the peaks and valleys of Structure Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 70.66%
Minimum Annual Increase = -144.35%
Minimum Annual ROE = -19.77%
Year | ROE | Change |
---|---|---|
2023 | -19.77% | -144.35% |
2022 | 44.57% | -24.17% |
2021 | 58.78% | -16.81% |
The current ROE of Structure Therapeutics Inc. (GPCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
27.86%
5-year avg
38.56%
10-year avg
38.56%
Structure Therapeutics Inc.’s ROE is greater than Day One Biopharmaceuticals, Inc. (-122.70%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than Mereo BioPharma Group plc (-63.39%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Amylyx Pharmaceuticals, Inc. (-46.15%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than Biomea Fusion, Inc. (-91.86%), greater than Disc Medicine, Inc. (-23.78%), greater than DICE Therapeutics, Inc. (-102.37%), greater than Morphic Holding, Inc. (-26.62%),
Company | ROE | Market cap |
---|---|---|
-122.70% | $1.25B | |
32.93% | $109.78M | |
-68.93% | $312.42M | |
-24.63% | $133.38M | |
-63.39% | $664.26M | |
-39.58% | $549.60M | |
-46.15% | $161.36M | |
-124.74% | $100.73M | |
-51.77% | $159.50M | |
-91.86% | $256.37M | |
-23.78% | $1.50B | |
-102.37% | $2.27B | |
-26.62% | $2.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Structure Therapeutics Inc.'s ROE?
How is the ROE calculated for Structure Therapeutics Inc. (GPCR)?
What is the highest ROE for Structure Therapeutics Inc. (GPCR)?
What is the 3-year average ROE for Structure Therapeutics Inc. (GPCR)?
What is the 5-year average ROE for Structure Therapeutics Inc. (GPCR)?
How does the current ROE for Structure Therapeutics Inc. (GPCR) compare to its historical average?